Best of ASCO® Toronto 2024: Special Session: Choosing Wisely in Cancer Care – Dr. Brooke Wilson
OR
Co-Chairs
Dr. Aly-Khan Lalani
Dr. Natasha Leighl
Speakers
Dr. Brooke Wilson
Studies/trials discussed:
- Surveillance Imaging After Curative-Intent Treatment for Cancer: Benefits, Harms, and Evidence
- Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
- Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108)
- Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy
- FAST-Forward Trial
- Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial
- Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial
